Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday

Published 25/01/2024, 12:42
© Reuters. AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
T
-
ISRG
-
INTU
-
BIIB
-
TSLA
-
CVLG
-
RMD
-
DECK
-
JD
-
HTZ
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Needham raised ResMed Inc. (NYSE: RMD) price target from $180 to $215. Needham analyst Mike Matson maintained a Buy rating. ResMed shares fell 1.8% to close at $171.78 on Wednesday. See how other analysts view this stock.
  • JP Morgan cut the price target for Hertz Global Holdings, Inc. (NASDAQ: HTZ) from $17 to $11. JP Morgan analyst Ryan Brinkman downgraded the stock from Overweight to Neutral. Hertz Global shares fell 2.8% to close at $8.49 on Wednesday. See how other analysts view this stock.
  • KGI Securities slashed the price target for Tesla, Inc. (NASDAQ: TSLA) from $309 to $213. KGI Securities analyst Jennifer Liang downgraded the stock from Outperform to Neutral. Tesla shares fell 0.6% to close at $207.83 on Wednesday. See how other analysts view this stock.
  • Deutsche Bank raised AT&T Inc. (NYSE: T) price target from $23 to $24. Deutsche Bank analyst Bryan Kraft maintained a Buy rating. AT&T shares fell 3% to close at $16.68 on Wednesday. See how other analysts view this stock.
  • Telsey Advisory Group boosted the price target for Deckers Outdoor Corporation (NYSE: DECK) from $800 to $850. Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating. Deckers Outdoor shares fell 0.5% to close at $750.62 on Wednesday. See how other analysts view this stock.
  • UBS cut the price target for Biogen Inc. (NASDAQ: BIIB) from $311 to $276. UBS analyst Colin Bristow downgraded the stock from Buy to Neutral. Biogen shares fell 1.8% to close at $247.16 on Wednesday. See how other analysts view this stock.
  • Raymond James raised Intuitive Surgical, Inc. (NASDAQ: ISRG) price target from $372 to $435. Raymond James analyst Jayson Bedford maintained an Outperform rating. Intuitive Surgical shares fell 0.4% to close at $370.07 on Wednesday. See how other analysts view this stock.
  • Keybanc boosted Intuit Inc. (NASDAQ: INTU) price target from $670 to $700. Keybanc analyst Alex Markgraff maintained an Overweight rating. Intuit shares rose 0.1% to close at $636.18 on Wednesday. See how other analysts view this stock.
  • TD Cowen increased Covenant Logistics Group, Inc. (NASDAQ: CVLG) price target from $51 to $66. TD Cowen analyst Jason Seidl upgraded the stock from Market Perform to Outperform. Covenant Logistics shares rose 1.9% to close at $49.85 on Wednesday. See how other analysts view this stock.
  • Citigroup cut JD.com, Inc. (NASDAQ: JD) price target from $43 to $42. Citigroup analyst Alicia Yap maintained a Buy rating. JD.com shares rose 1.6% to close at $23.60 on Wednesday. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: Tesla, American Airlines And 3 Stocks To Watch Heading Into Thursday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.